United States · Seed startup

Who invested in Acumen Pharmaceuticals

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$2.2Mraised across 2 rounds since 2006, from 2 sources

$1.5MVenture$700KSeed
Latest round
Seed, $700KMay 2013
Biggest round
$1.5MVenture · Aug 2006
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2007200820092010201120122013
$1.5MVenture$700KSeed
First round
Venture, $1.5M
Aug 2006
Biggest round
$1.5M
Venture · Aug 2006
Between rounds
6.8 years
from the last two

The rounds

  1. May 2013
    Seed$700K

    No investor was named in the report.

    Reported by sec.govSEC filing: $700K sold, first sale Apr 2013

  2. Aug 2006
    Venture$1.5M1 new

    From a historical funding record

Everyone who backed them

NeuroVenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Acumen Pharmaceuticals

Who invested in Acumen Pharmaceuticals?

Acumen Pharmaceuticals's investors include NeuroVentures.

How much has Acumen Pharmaceuticals raised?

Acumen Pharmaceuticals has raised $2.2M across 2 rounds since 2006.

When did Acumen Pharmaceuticals last raise?

Acumen Pharmaceuticals's most recent round was a Seed of $700K in May 2013.

What was Acumen Pharmaceuticals's biggest round?

Acumen Pharmaceuticals's largest round on record is $1.5M (Venture), in Aug 2006.

Who backed Acumen Pharmaceuticals first?

Acumen Pharmaceuticals's first round on record, in Aug 2006, was backed by NeuroVentures.

What stage is Acumen Pharmaceuticals at?

Acumen Pharmaceuticals's latest named round is a Seed, in May 2013.

Where is Acumen Pharmaceuticals based?

Acumen Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.